A Phase 2/3 interventional study of Tadalafil 5mg and Placebo in Sexual Dysfunction, sponsored by Kasr El Aini Hospital. Status unknown at 1 site in Egypt. Open to female participants aged 25 Years to 35 Years. Per ClinicalTrials.gov, last updated 2022-03-04.
Sponsored by Kasr El Aini Hospital · Phase 2/3, Interventional, and Treatment
comparative study between tadalafil versus placebo effect for the management of circumsized female
the group of patient will be randomly divided into 2 groups, half of the patients will receive tadalafil and the other half will receive placebo
125 studies on the registry are indexed under Sexual Dysfunction, Physiological; 45 are open to participants now.
This study's planned enrollment of 24 is below the median of 60 across 88 interventional studies indexed under Sexual Dysfunction, Physiological.
Browse Sexual Dysfunction, Physiological studies →Kasr El Aini Hospital is the lead sponsor of 283 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
5 mg of Tadalafil on daily bases for one month duration
Drug: Tadalafil 5mg
the patients will receive oral tablets without any active substance for one month
Drug: Placebo
oral tablets for one month duration
oral tablets for one month duration
clitorial Artery Doppler
Pulsatile index
Time frame: after one month duration of drug use
Clitorial artery doppler
Resistance index
Time frame: after one month duration of drug use
Clitorial artery doppler
Peak systolic velosity
Time frame: after one month duration of drug use
score of sexual function
arousal orgasm frequency
Time frame: after on month of the drug use
Plan to share: Yes — the exel sheet
Supporting information: Study protocol, Statistical analysis plan
No publications or documents are linked to this record.
This study is status unknown, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tadalafil
Sexual Dysfunction, Physiological →